PK

Pardeep Kumar Jain

Active Director Director DIN 08547992
DIN 08547992 First appointment Aug 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Pardeep Kumar Jain

Data last updated:

Pardeep Kumar Jain is a Director at Clinivex Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Clinivex Pharmaceuticals Private Limited reported revenue of ₹61.32 Cr (FY 2024).

DIN 08547992
Primary Designation Director
Industry Pharma
First Appointment 27 Aug 2019
Oldest Company Age 7 yrs
Largest company Clinivex Pharmaceuticals Private Limited · ₹61.32 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Aug 20192019₹61.32 Cr (FY 2024)Active

Board colleagues of Pardeep Kumar Jain

NameDINCompanyDesignation
Kajal Jain08547991Clinivex Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Clinivex Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pardeep Kumar Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pardeep Kumar Jain

Pardeep Kumar Jain currently holds 1 directorship: Clinivex Pharmaceuticals Private Limited (Director, since 27 Aug 2019, revenue ₹61.32 Cr (FY 2024)).

Pardeep Kumar Jain was first appointed on 27 Aug 2019 as Director at Clinivex Pharmaceuticals Private Limited.

The current boards of Pardeep Kumar Jain's companies include Kajal Jain (Clinivex Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available